Calling all bioxcel therapeutics, inc. (btai) investors: contact bronstein, gewirtz & grossman, llc to claim your losses!

New york--(business wire)---- $btai #classaction--attorney advertising--bronstein, gewirtz & grossman, llc, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against bioxcel therapeutics, inc. (“bioxcel” or the “company”) (nasdaq: btai) and certain of its officers. class definition: this lawsuit seeks to recover damages against defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired bi.
BTAI Ratings Summary
BTAI Quant Ranking